Verbesselt R - Search Results

1

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers.

De Lepeleire I, Van Hecken A, Verbesselt R, Kaiser G, Barner A, Holmes I, De Schepper PJ. De Lepeleire I, et al. Among authors: verbesselt r. Eur J Clin Pharmacol. 1988;34(5):465-8. doi: 10.1007/BF01046703. Eur J Clin Pharmacol. 1988. PMID: 3203706 Clinical Trial.

2

Lack of interaction between famotidine and warfarin.

De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, Buntinx A, Distlerath L, De Schepper PJ. De Lepeleire I, et al. Among authors: verbesselt r. Int J Clin Pharmacol Res. 1990;10(3):167-71. Int J Clin Pharmacol Res. 1990. PMID: 2228341

3

Pharmacokinetic interaction between indomethacin and diflunisal.

Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ. Van Hecken A, et al. Among authors: verbesselt r. Eur J Clin Pharmacol. 1989;36(5):507-12. doi: 10.1007/BF00558077. Eur J Clin Pharmacol. 1989. PMID: 2753070

4

Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin.

Van Hecken A, De Lepeleire I, Verbesselt R, Arnout J, Angehrn J, Youngberg C, De Schepper PJ. Van Hecken A, et al. Among authors: verbesselt r. Int J Clin Pharmacol Res. 1988;8(5):315-9. Int J Clin Pharmacol Res. 1988. PMID: 3229872

5

Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin.

Van Hecken A, Verbesselt R, Depré M, Tjandramaga TB, Angehrn J, Cawello W, De Schepper PJ. Van Hecken A, et al. Among authors: verbesselt r. Eur J Clin Pharmacol. 1993;45(3):291-3. doi: 10.1007/BF00315400. Eur J Clin Pharmacol. 1993. PMID: 8276058 Clinical Trial.

6

Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.

Depré M, Van Hecken A, Verbesselt R, De Lepeleire I, Schwartz J, Porras A, Larson P, Lin C, De Schepper PJ. Depré M, et al. Among authors: verbesselt r. Int J Clin Pharmacol Res. 1998;18(2):53-61. Int J Clin Pharmacol Res. 1998. PMID: 9675622 Clinical Trial.

7

Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Van Hecken A, Depré M, Verbesselt R, Wynants K, De Lepeleire I, Arnout J, Wong PH, Freeman A, Holland S, Gertz B, De Schepper PJ. Van Hecken A, et al. Among authors: verbesselt r. J Clin Pharmacol. 1999 May;39(5):495-500. J Clin Pharmacol. 1999. PMID: 10234597 Clinical Trial.

8

Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteers.

Depré M, Van Hecken A, Verbesselt R, Wynants K, De Lepeleire I, Freeman A, Holland S, Shahane A, Gertz B, De Schepper PJ. Depré M, et al. Among authors: verbesselt r. J Clin Pharmacol. 1999 Sep;39(9):941-4. doi: 10.1177/00912709922008579. J Clin Pharmacol. 1999. PMID: 10471986 Clinical Trial.

9

Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use.

Depré M, van Hecken A, Verbesselt R, Tjandra-Maga TB, Gerin M, de Schepper PJ. Depré M, et al. Among authors: verbesselt r. Fundam Clin Pharmacol. 1992;6(6):259-62. doi: 10.1111/j.1472-8206.1992.tb00119.x. Fundam Clin Pharmacol. 1992. PMID: 1487229 Clinical Trial.

10

Absence of a pharmacokinetic interaction between enalapril and frusemide.

Van Hecken AM, Verbesselt R, Buntinx A, Cirillo VJ, De Schepper PJ. Van Hecken AM, et al. Among authors: verbesselt r. Br J Clin Pharmacol. 1987 Jan;23(1):84-7. doi: 10.1111/j.1365-2125.1987.tb03013.x. Br J Clin Pharmacol. 1987. PMID: 3028456 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters